"Designing Growth Strategies is in our DNA"

Diabetic Nephropathy Market Size, Share & Industry Analysis, By Drug Class (Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors, Mineralocorticoid Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2024-2032

Last Updated: November 04, 2024 | Format: PDF | Report ID: FBI102012

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Key Industry Developments – Merges, Acquisitions, and Partnerships
    2. New Product Launches, By Key Players
    3. Prevalence of Diabetic Nephropathy, By Key Countries
    4. Pipeline Analysis (Analysis by Stage, Route of Administration, Molecule Type, Sponsor, etc.)
    5. Insights on Usage of SGLT2 Inhibitors in CKD Stage 3 Patients
    6. Drugs Delaying Dialysis Onset: Analysis of Ongoing Studies
    7. List of Research & Educational Institutes in R&D
    8. Impact of COVID 19 on the Global Diabetic Nephropathy Market
  5. Global Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
  8. 7.3.4.I taly
      1. Spain
      2. Scandinavia
      3. Rest of Europe
  9. Asia Pacific Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  10. Rest of the World Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
  11. Comparative Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Janssen Pharmaceuticals, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Aurobindo Pharmaceuticals
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bayer AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Par Pharmaceutical
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sun Pharmaceutical Industries
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Diabetic Nephropathy Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 02: Global Diabetic Nephropathy Market Revenue Share (%), By Drug Class, 2023 & 2032

Figure 03: Global Diabetic Nephropathy Market Revenue Share (%), By Distribution Channel, 2023 & 2032

Figure 04: Global Diabetic Nephropathy Market Value (USD billion), by Region, 2023 & 2032

Figure 05: North America Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 06: North America Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 07: North America Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 08: North America Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 09: North America Diabetic Nephropathy Market Value (USD billion), by Country, 2023 & 2032

 Figure 10: North America Diabetic Nephropathy Market Value Share (%), by Country, 2023

Figure 11: Europe Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 12: Europe Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 13: Europe Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 14: Europe Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 15: Europe Diabetic Nephropathy Market Value (USD billion), by Country/Sub-Region, 2023 & 2032

Figure 16: Europe Diabetic Nephropathy Market Value Share (%), by Country/Sub-Region, 2023

Figure 17: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 18: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 19: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 20: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 21: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Country/Sub-Region, 2023 & 2032

Figure 22: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Country/Sub-Region, 2023

Figure 23: Rest of the World Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 24: Rest of the World Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 25: Rest of the World Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 26: Rest of the World Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 27: Global Diabetic Nephropathy Market Share (%), By Company, 2023

Table 01: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 02: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 03: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 04: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 05: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 06: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country, 2019–2032

Table 07: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 08: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 09: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 10: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 11: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 13: Rest of the World Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 14: Rest of the World Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Diabetic Nephropathy Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 120
  • Buy Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X